This protocol addresses pemphigoid gestationis presenting with active disease during pregnancy — specifically excluding the post-partum and post-abortion periods. The concurrent requirement to manage an autoimmune blistering disorder while protecting the pregnancy shapes the treatment approach.
The protocol involves adjustment of systemic corticosteroid therapy to achieve disease control.
Increase SCs dosage (up to prednisone 1 mg/kg/day)
DOI: 10.3389/fmed.2020.604945
View source ↗